Healthcare

Syngene International Ltd

SYNGENE · NSE · INE398R01022
₹385.7-0.46%consolidatedstandalone
Wednesday, 9 Sept 202611:02 am
Sentiment25 · Fear
Extreme FearFearNeutralGreedExtreme Greed
Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE7.8%
ROCE10.0%
ROE7.8%
1Y Return-38.79%
Avg. Volume1.4M

Price Chart

6716005284573863.0Cr5.9CrSept 2025Oct 2025Nov 2025Jan 2026Feb 2026Mar 2026May 2026Jul 2026Sept 2026

52-Week Range

₹375.25₹385.7₹678.95
52W Low52W High

About

Syngene International Ltd is a Healthcare company listed on NSE.

Healthcare

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap—
Current Price₹385.7
52W High / Low₹678.95 / ₹375.25
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE7.8%
1Y Return-38.79%
Day Change-0.46%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18
Sales₹3,600 Cr₹3,739 Cr₹3,642 Cr
Expenses₹2,797 Cr₹2,817 Cr₹2,598 Cr
Operating Profit₹803 Cr₹921 Cr₹1,045 Cr
OPM %22.0%25.0%29.0%
Other Income₹-12 Cr₹-9 Cr₹101 Cr
Depreciation₹454 Cr₹453 Cr₹433 Cr
Interest₹47 Cr₹49 Cr₹53 Cr
Profit Before Tax₹290 Cr₹411 Cr₹660 Cr
Tax₹69 Cr₹94 Cr₹164 Cr
Net Profit₹221 Cr₹317 Cr₹496 Cr
EPS (₹)5.57.912.3
Dividend Payout %—16%10%
Financial history locked

Register free to see 7 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹736 Cr₹1,037 Cr₹917 Cr₹911 Cr
Expenses₹645 Cr₹733 Cr₹708 Cr₹711 Cr
Operating Profit₹91 Cr₹303 Cr₹209 Cr₹200 Cr
OPM %12.3%29.3%22.8%21.9%
Depreciation₹112 Cr₹112 Cr₹114 Cr₹117 Cr
Interest₹10 Cr₹12 Cr₹12 Cr₹13 Cr
Net Profit₹-9 Cr₹148 Cr₹15 Cr₹67 Cr
EPS (₹)-0.23.70.41.7
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18
Liabilities
Equity Capital₹403 Cr₹402 Cr₹402 Cr
Reserves₹4,436 Cr₹4,324 Cr₹3,856 Cr
Borrowings₹458 Cr₹578 Cr₹555 Cr
Other Liabilities₹1,758 Cr₹1,492 Cr₹1,339 Cr
Total Liabilities₹7,055 Cr₹6,796 Cr₹6,152 Cr
Assets
Fixed Assets₹3,000 Cr₹2,802 Cr₹2,850 Cr
Investments₹741 Cr₹647 Cr₹548 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹2,268 Cr₹2,081 Cr₹1,916 Cr
Total Assets₹7,055 Cr₹6,796 Cr₹6,152 Cr
Balance sheet history locked

Register free to see 7 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹915 Cr₹-839 Cr₹-215 Cr₹-138 Cr
FY25₹1,168 Cr₹-744 Cr₹-142 Cr₹281 Cr
FY24₹1,042 Cr₹-494 Cr₹-551 Cr₹-4 Cr
FY23
FY22
FY21
FY20
FY19
FY18
Cash flow history locked

Register free to see 7 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
Dr. Agarwals Health Care Ltd——+8.63%+3.15%
Fabtech Technologies Ltd₹656 Cr13.5+12.5%-21.51%
Fischer Medical Ventures Ltd——+8.59%-10.66%
Inventurus Knowledge Solutions Ltd——+31.4%+7.00%
Indegene Ltd——+14.4%+14.54%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-01Grant Of Performance Share Units Under Syngene Long Term Incentive Performance Share Plan (PSP) 2023 ('Plan')BSE Filing2026-07-01Siddharth Mittal Appointed as Managing Director & CEO of Syngene InternationalPR Newswire

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.